A process is provided for preparing 4-(8-(2-chlorophenoxy)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)bicyclo[2.2.1]heptan-1-ol and novel intermediates used in the process. The compound is a 11-beta hydroxysteroid dehydrogenase type I inhibitor which exhibits activity in the treatment of various metabolic diseases.
                            提供了一种制备4-(8-(2-
氯苯氧)-[1,2,4]三唑[4,3-a]
吡啶-3-基)
双环[2.2.1]庚烷-1-醇及其在该过程中使用的新型中间体的方法。该化合物是一种11-β羟基类
固醇脱氢酶I
抑制剂,具有治疗多种代谢性疾病的活性。